These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 191528)

  • 21. Lymphocyte transformation for the detection of herpesvirus-induced tumor-associated antigens.
    Harris LF; Hamparian VV; Young EA; Hughes JH
    Cancer Res; 1979 Oct; 39(10):3996-4002. PubMed ID: 225013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody and cell-mediated immunity to herpes simplex virus in psychotic depression.
    Cappel R; Gregoire F; Thiry L; Sprecher S
    J Clin Psychiatry; 1978 Mar; 39(3):266-8. PubMed ID: 204625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevention and therapy of herpesvirus infections].
    Abb J
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either gamma delta or alpha beta T-cell receptor: role of accessory molecules on HLA-unrestricted killing of virus-infected targets.
    Maccario R; Comoli P; Percivalle E; Montagna D; Locatelli F; Gerna G
    Immunology; 1995 May; 85(1):49-56. PubMed ID: 7635521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
    Kohl S; Loo LS
    J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific in vitro antibody response to varicella zoster.
    Souhami RL; Babbage J; Callard RE
    Clin Exp Immunol; 1981 Oct; 46(1):98-105. PubMed ID: 6279341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma.
    Arvin AM; Pollard RB; Rasmussen LE; Merigan TC
    J Clin Invest; 1980 Apr; 65(4):869-78. PubMed ID: 6244336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leukocyte migration inhibitory factor in HSV infections.
    Centifanto YM; Zam ZS; McNeill JI; Kaufman HE
    Invest Ophthalmol Vis Sci; 1978 Sep; 17(9):863-8. PubMed ID: 212384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human immune responses to herpes simplex virus, varicella-zoster and cytomegalovirus in vitro.
    Williamson SA; Parish N; Chambers JD; Knight RA
    Immunology; 1986 Mar; 57(3):437-42. PubMed ID: 3007334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The lymphocyte transformation test in patients with recurrent herpes simplex diseases (author's transl)].
    Wassilew SW; Koch I
    Arch Dermatol Res; 1978 Aug; 262(3):267-74. PubMed ID: 214045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infection with herpes simplex virus and cell-mediated immunity after marrow transplant.
    Meyers JD; Flournoy N; Thomas ED
    J Infect Dis; 1980 Sep; 142(3):338-46. PubMed ID: 6255035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The herpes-specific immune response of individuals with herpes-associated erythema multiforme compared with that of individuals with recurrent herpes labialis.
    Brice SL; Stockert SS; Bunker JD; Bloomfield D; Huff JC; Norris DA; Weston WL
    Arch Dermatol Res; 1993; 285(4):193-6. PubMed ID: 8342962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunity to herpes simplex virus type 2: cell-mediated immunity in latently infected guinea pigs.
    Donnenberg AD; Chaikof E; Aurelian L
    Infect Immun; 1980 Oct; 30(1):99-109. PubMed ID: 6254886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-mediated immunity in human herpesvirus infection: analysis by monoclonal antibodies.
    Peterman GM; Altman LC; Corey L
    Clin Immunol Immunopathol; 1985 Oct; 37(1):83-92. PubMed ID: 2992858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA antigens in patients with recrudescent herpes simplex infections.
    Legendre C; Russell AS; Jeannet M
    Tissue Antigens; 1982 Jan; 19(1):85-9. PubMed ID: 6280337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Depressed specific cell-mediated immunity to Herpes simplex virus type 1 in patients with recurrent herpes labialis.
    Thong YH; Vincent MM; Hensen SA; Fuccillo DA; Rola-Pleszczynski M; Bellanti JA
    Infect Immun; 1975 Jul; 12(1):76-80. PubMed ID: 166930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-mediated immunity in Herpesvirus hominis infections.
    Wilton JM; Ivanyi L; Lehner T
    Br Med J; 1972 Mar; 1(5802):723-6. PubMed ID: 4552465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell mediated immunity to herpes simplex in man. IV. A correlation of lymphocyte stimulation and inhibition of leukocyte migration.
    Russell AS; Kaiser J; Lao VS
    J Immunol Methods; 1976; 9(3-4):273-9. PubMed ID: 175120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro studies on the human cellular immune response to commercially available herpes simplex antigens.
    Czarnetzki BM; Macher E
    Arch Dermatol Res; 1980; 268(3):247-55. PubMed ID: 7212769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of clinical and virus-specific immune responses following levamisole therapy of recurrent herpes progenitalis.
    O'Reilly RJ; Chibbaro A; Wilmot R; Lopez C
    Ann N Y Acad Sci; 1977 Mar; 284():161-70. PubMed ID: 212971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.